The significant advances in the surgical and medical treatment of gynecological cancer have led to improved survival outcomes of several subgroups of patients that were until recently opted out of treatment plans. Surgical cytoreduction has evolved through advanced surgical complexity procedures and the need for critical care of gynecological cancer patients has increased. Despite that, however, articles focusing on the need of perioperative monitoring of these patients completely lack from the international literature; hence, recommendations are still lacking. Critical care may be offered in different types of facilities with specific indications. These include the post-anesthesia care unit (PACU), the high dependency unit (HDU) and the intensive care unit (ICU) which have discrete roles and should be used judiciously in order to avoid unnecessary increases in the hospitalization costs. In the present review we focus on the pathophysiological alterations that are expected in gynecological cancer patients undergoing surgical treatment, provide current evidence and discuss indications of hospitalization as well as discharge criteria from intensive care facilities.
妇科癌症外科与内科治疗的显著进展，使多个亚组患者的生存结局得到改善，这些患者直到最近还被排除在治疗方案之外。通过先进复杂手术的发展，肿瘤细胞减灭术不断演进，妇科癌症患者对重症监护的需求也随之增加。然而，尽管需求增长，国际文献中完全缺乏关注这些患者围手术期监护必要性的文章，因此相关建议仍属空白。重症监护可在具备特定适应症的不同类型设施中提供，包括麻醉后监护室（PACU）、高度依赖病房（HDU）和重症监护室（ICU）。这些设施职能各异，应审慎使用以避免不必要的住院费用增加。本综述重点关注接受手术治疗的妇科癌症患者可能出现的病理生理变化，提供现有证据，并讨论重症监护设施的住院指征及出院标准。
肿瘤(癌症)患者之家